RYTM
Rhythm Pharmaceuticals Inc
NASDAQ: RYTM · HEALTHCARE · BIOTECHNOLOGY
$82.12
-2.45% today
Updated 2026-04-29
Market cap
$5.61B
P/E ratio
—
P/S ratio
29.55x
EPS (TTM)
$-3.11
Dividend yield
—
52W range
$55 – $122
Volume
0.9M
Rhythm Pharmaceuticals Inc (RYTM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-17.83M | $-19.16M | $-7.51M | $-6.98M | $-23.22M | $-29.46M | $-62.06M | $-122.75M | $-121.98M | $-146.00M | $-173.43M | $-136.16M | $-113.88M | $-115.67M |
| Capital expenditures | $0.00 | $0.00 | $17000.00 | $17000.00 | $1.06M | $133000.00 | $722000.00 | $3.38M | $214000.00 | $5.43M | $4.28M | $47000.00 | $0.00 | $953000.00 |
| Depreciation | $17000.00 | $20000.00 | $144000.00 | $144000.00 | $144000.00 | $223000.00 | $442000.00 | $834000.00 | $690000.00 | $1.16M | $1.67M | $1.76M | $1.56M | — |
| Stock-based comp | — | $127000.00 | $66000.00 | $298000.00 | $1.17M | $2.28M | $6.39M | $11.88M | $17.45M | $20.80M | $19.83M | $32.55M | $39.68M | $66.82M |
| Free cash flow | $-17.83M | $-19.16M | $-7.53M | $-6.99M | $-24.28M | $-29.59M | $-62.78M | $-126.14M | $-122.19M | $-151.44M | $-177.71M | $-136.20M | $-113.88M | $-116.63M |
| Investing cash flow | $-5.27M | $-5.13M | $-17000.00 | $-17000.00 | $-5.11M | $-110.04M | $-87.15M | $-27.97M | $158.53M | $-62.16M | $28.03M | $-5.67M | $-48.17M | — |
| Financing cash flow | $22.44M | $19.88M | $7.42M | $41.71M | $0.00 | $167.20M | $164.69M | $163.47M | $2.01M | $166.48M | $213.83M | $74.37M | $191.24M | — |
| Dividends paid | — | — | — | — | — | $0.00 | — | — | — | — | — | — | $3.97M | $5.38M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $27.70M | $15.48M | $12.75M | $38.56M | $-41.68M | $68.43M | — | — | — |